Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, X-Ray Computed | 25 | 2024 | 20509 | 0.580 |
Why?
|
Pancreatic Cyst | 5 | 2022 | 367 | 0.570 |
Why?
|
Breast | 3 | 2023 | 1963 | 0.510 |
Why?
|
Mammography | 9 | 2023 | 2427 | 0.440 |
Why?
|
Iohexol | 4 | 2019 | 204 | 0.440 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 5 | 2023 | 936 | 0.420 |
Why?
|
Breast Neoplasms | 17 | 2023 | 21029 | 0.410 |
Why?
|
Contrast Media | 12 | 2021 | 5305 | 0.410 |
Why?
|
Radiology | 5 | 2023 | 2102 | 0.380 |
Why?
|
Radiographic Image Enhancement | 6 | 2019 | 875 | 0.360 |
Why?
|
Pancreatic Neoplasms | 7 | 2023 | 5349 | 0.330 |
Why?
|
Ovarian Cysts | 2 | 2021 | 108 | 0.320 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 7 | 2019 | 1214 | 0.320 |
Why?
|
Photography, Dental | 1 | 2008 | 22 | 0.310 |
Why?
|
Magnetic Resonance Imaging | 22 | 2023 | 36286 | 0.310 |
Why?
|
Pelvis | 5 | 2023 | 743 | 0.300 |
Why?
|
Gingivitis | 1 | 2008 | 124 | 0.290 |
Why?
|
Breast Diseases | 2 | 2023 | 443 | 0.280 |
Why?
|
Retrospective Studies | 44 | 2024 | 80345 | 0.280 |
Why?
|
Radiography, Abdominal | 4 | 2018 | 532 | 0.280 |
Why?
|
Abdomen | 3 | 2023 | 1130 | 0.270 |
Why?
|
Carcinoma, Lobular | 2 | 2021 | 489 | 0.260 |
Why?
|
Incidental Findings | 6 | 2023 | 698 | 0.250 |
Why?
|
Pancreatitis | 2 | 2023 | 1100 | 0.230 |
Why?
|
Sensitivity and Specificity | 18 | 2021 | 14661 | 0.230 |
Why?
|
Body Surface Area | 1 | 2024 | 197 | 0.220 |
Why?
|
Needles | 2 | 2024 | 451 | 0.220 |
Why?
|
Documentation | 2 | 2023 | 893 | 0.210 |
Why?
|
Precancerous Conditions | 2 | 2021 | 977 | 0.210 |
Why?
|
International Normalized Ratio | 1 | 2024 | 387 | 0.200 |
Why?
|
Cystadenoma | 1 | 2021 | 79 | 0.200 |
Why?
|
Cystadenoma, Mucinous | 1 | 2021 | 62 | 0.190 |
Why?
|
Discitis | 1 | 2022 | 45 | 0.190 |
Why?
|
Radar | 1 | 2021 | 11 | 0.190 |
Why?
|
Pancreas | 6 | 2023 | 1677 | 0.190 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2023 | 1200 | 0.180 |
Why?
|
Middle Aged | 50 | 2024 | 220359 | 0.180 |
Why?
|
Endometrial Hyperplasia | 1 | 2021 | 97 | 0.180 |
Why?
|
Endometrial Neoplasms | 2 | 2021 | 1357 | 0.180 |
Why?
|
Heart Atria | 2 | 2024 | 1346 | 0.180 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2020 | 66 | 0.180 |
Why?
|
Radiation Pneumonitis | 1 | 2020 | 102 | 0.170 |
Why?
|
Aged | 42 | 2024 | 169143 | 0.170 |
Why?
|
Mastectomy, Segmental | 3 | 2021 | 972 | 0.170 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2019 | 100 | 0.170 |
Why?
|
Predictive Value of Tests | 9 | 2024 | 15286 | 0.170 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2543 | 0.160 |
Why?
|
Female | 60 | 2024 | 391246 | 0.160 |
Why?
|
Angiography | 2 | 2024 | 1605 | 0.160 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1722 | 0.160 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2018 | 35 | 0.160 |
Why?
|
Optic Atrophy | 1 | 2019 | 78 | 0.160 |
Why?
|
Humans | 76 | 2024 | 760613 | 0.150 |
Why?
|
Radiography, Interventional | 3 | 2024 | 1112 | 0.150 |
Why?
|
Radiation Dosage | 5 | 2021 | 1957 | 0.150 |
Why?
|
Arnold-Chiari Malformation | 1 | 2020 | 158 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 407 | 0.150 |
Why?
|
Spleen | 1 | 2024 | 2298 | 0.150 |
Why?
|
Embolization, Therapeutic | 2 | 2020 | 1412 | 0.140 |
Why?
|
Patient Care Planning | 2 | 2014 | 908 | 0.140 |
Why?
|
Endoleak | 1 | 2017 | 105 | 0.140 |
Why?
|
Pneumothorax | 1 | 2020 | 379 | 0.140 |
Why?
|
Spine | 2 | 2021 | 1111 | 0.140 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 343 | 0.130 |
Why?
|
Troponin T | 1 | 2021 | 774 | 0.130 |
Why?
|
Practice Management, Medical | 1 | 2018 | 191 | 0.130 |
Why?
|
Cysts | 1 | 2021 | 683 | 0.130 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2020 | 377 | 0.130 |
Why?
|
Aged, 80 and over | 20 | 2024 | 58980 | 0.130 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 194 | 0.130 |
Why?
|
Teaching Materials | 1 | 2016 | 84 | 0.130 |
Why?
|
Diagnostic Imaging | 4 | 2023 | 3527 | 0.130 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 796 | 0.130 |
Why?
|
Cough | 1 | 2020 | 595 | 0.130 |
Why?
|
Ultrasonography, Interventional | 1 | 2024 | 1501 | 0.130 |
Why?
|
Artifacts | 3 | 2017 | 1898 | 0.130 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 4046 | 0.130 |
Why?
|
Fellowships and Scholarships | 1 | 2023 | 1116 | 0.120 |
Why?
|
Reproducibility of Results | 12 | 2021 | 20080 | 0.120 |
Why?
|
Outpatients | 1 | 2023 | 1607 | 0.120 |
Why?
|
Head | 1 | 2021 | 922 | 0.120 |
Why?
|
Metals | 2 | 2017 | 736 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2018 | 9278 | 0.120 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 517 | 0.120 |
Why?
|
Colonic Pouches | 1 | 2015 | 122 | 0.120 |
Why?
|
Kidney Neoplasms | 3 | 2017 | 4312 | 0.120 |
Why?
|
Peer Review, Health Care | 1 | 2014 | 73 | 0.120 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2017 | 200 | 0.110 |
Why?
|
Bone Marrow | 1 | 2024 | 2914 | 0.110 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2015 | 218 | 0.110 |
Why?
|
Lung | 3 | 2023 | 9994 | 0.110 |
Why?
|
Endovascular Procedures | 2 | 2017 | 2134 | 0.110 |
Why?
|
Osteoporotic Fractures | 1 | 2018 | 409 | 0.110 |
Why?
|
Postmenopause | 2 | 2021 | 2509 | 0.110 |
Why?
|
Adult | 31 | 2024 | 220007 | 0.110 |
Why?
|
Workflow | 1 | 2018 | 852 | 0.110 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4878 | 0.100 |
Why?
|
Foot Injuries | 1 | 2014 | 149 | 0.100 |
Why?
|
Computer Graphics | 1 | 2014 | 341 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 8950 | 0.100 |
Why?
|
Aortic Aneurysm | 1 | 2017 | 646 | 0.100 |
Why?
|
Internship and Residency | 3 | 2022 | 5870 | 0.100 |
Why?
|
Radiology, Interventional | 1 | 2016 | 475 | 0.100 |
Why?
|
Headache | 1 | 2020 | 1249 | 0.100 |
Why?
|
Spinal Fractures | 1 | 2018 | 702 | 0.100 |
Why?
|
Gelatin | 1 | 2012 | 221 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2018 | 1096 | 0.090 |
Why?
|
Drainage | 1 | 2017 | 1161 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2634 | 0.090 |
Why?
|
Male | 33 | 2024 | 359718 | 0.090 |
Why?
|
Video Recording | 1 | 2016 | 955 | 0.090 |
Why?
|
Fiducial Markers | 1 | 2012 | 132 | 0.090 |
Why?
|
Observer Variation | 3 | 2016 | 2601 | 0.090 |
Why?
|
Ultrasonography | 3 | 2020 | 5961 | 0.090 |
Why?
|
Biopsy | 3 | 2023 | 6771 | 0.090 |
Why?
|
Software | 2 | 2014 | 4419 | 0.090 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1273 | 0.090 |
Why?
|
Tumor Burden | 1 | 2016 | 1895 | 0.090 |
Why?
|
Lymph Nodes | 2 | 2018 | 3486 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2019 | 6316 | 0.080 |
Why?
|
Medical Records | 1 | 2014 | 1407 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3839 | 0.080 |
Why?
|
Communication | 1 | 2023 | 3849 | 0.080 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2363 | 0.080 |
Why?
|
Prostatic Hyperplasia | 1 | 2012 | 530 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1403 | 0.080 |
Why?
|
Data Collection | 2 | 2014 | 3315 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7510 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2299 | 0.080 |
Why?
|
Periodontal Index | 1 | 2008 | 151 | 0.080 |
Why?
|
Athletic Injuries | 1 | 2018 | 1209 | 0.070 |
Why?
|
Quality Improvement | 1 | 2023 | 3835 | 0.070 |
Why?
|
Endometrium | 2 | 2021 | 403 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13262 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 2049 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2782 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 2015 | 1152 | 0.070 |
Why?
|
Colorimetry | 1 | 2007 | 153 | 0.070 |
Why?
|
Hyperplasia | 2 | 2021 | 1155 | 0.070 |
Why?
|
Radiosurgery | 1 | 2016 | 1343 | 0.070 |
Why?
|
Nephrectomy | 1 | 2012 | 1016 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3484 | 0.070 |
Why?
|
Color | 1 | 2007 | 298 | 0.070 |
Why?
|
Algorithms | 5 | 2017 | 13982 | 0.070 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 1431 | 0.060 |
Why?
|
Bone Density | 1 | 2018 | 3534 | 0.060 |
Why?
|
Calcinosis | 1 | 2014 | 1476 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4319 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4591 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2020 | 3340 | 0.060 |
Why?
|
Prostate | 1 | 2012 | 1793 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2017 | 15679 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2014 | 2176 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2315 | 0.060 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1919 | 0.050 |
Why?
|
Crohn Disease | 1 | 2015 | 2275 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7818 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 2041 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2014 | 4563 | 0.050 |
Why?
|
Bilirubin | 1 | 2024 | 438 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3218 | 0.050 |
Why?
|
Radiography | 2 | 2023 | 6965 | 0.050 |
Why?
|
Acute Disease | 2 | 2023 | 7268 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 3026 | 0.050 |
Why?
|
Clinical Audit | 1 | 2021 | 30 | 0.050 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2020 | 66 | 0.050 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3202 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2023 | 39262 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5640 | 0.050 |
Why?
|
Liver Circulation | 1 | 2020 | 159 | 0.050 |
Why?
|
Hemorrhage | 2 | 2024 | 3599 | 0.040 |
Why?
|
Morals | 1 | 2023 | 289 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9406 | 0.040 |
Why?
|
Chest Tubes | 1 | 2020 | 152 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2024 | 1630 | 0.040 |
Why?
|
Retreatment | 1 | 2020 | 600 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2018 | 2210 | 0.040 |
Why?
|
Hemoptysis | 1 | 2020 | 152 | 0.040 |
Why?
|
Phantoms, Imaging | 2 | 2018 | 2512 | 0.040 |
Why?
|
Organ Size | 1 | 2024 | 2254 | 0.040 |
Why?
|
Ovarian Follicle | 1 | 2020 | 244 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 8022 | 0.040 |
Why?
|
Pleura | 1 | 2020 | 244 | 0.040 |
Why?
|
Encephalocele | 1 | 2020 | 135 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2021 | 5201 | 0.040 |
Why?
|
Neoplasms | 2 | 2022 | 22075 | 0.040 |
Why?
|
Creatinine | 1 | 2024 | 1904 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7408 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 743 | 0.040 |
Why?
|
Edema | 1 | 2022 | 770 | 0.040 |
Why?
|
Pandemics | 3 | 2023 | 8623 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2022 | 643 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2010 | 3598 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8556 | 0.030 |
Why?
|
Back Pain | 1 | 2021 | 543 | 0.030 |
Why?
|
Kidney | 1 | 2012 | 7064 | 0.030 |
Why?
|
Necrosis | 1 | 2020 | 1612 | 0.030 |
Why?
|
Image Enhancement | 1 | 2007 | 2881 | 0.030 |
Why?
|
Prospective Studies | 5 | 2021 | 54306 | 0.030 |
Why?
|
Ultrasonography, Mammary | 1 | 2018 | 239 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1166 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5659 | 0.030 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2016 | 190 | 0.030 |
Why?
|
Optic Nerve | 1 | 2019 | 567 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2017 | 1385 | 0.030 |
Why?
|
Chest Pain | 1 | 2022 | 1106 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7475 | 0.030 |
Why?
|
Trachea | 1 | 2020 | 1082 | 0.030 |
Why?
|
Software Validation | 1 | 2014 | 59 | 0.030 |
Why?
|
Mass Screening | 2 | 2021 | 5422 | 0.030 |
Why?
|
Computers, Handheld | 1 | 2016 | 210 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6659 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2018 | 1130 | 0.030 |
Why?
|
Patient Preference | 1 | 2021 | 922 | 0.030 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 697 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1110 | 0.030 |
Why?
|
Incidence | 2 | 2022 | 21391 | 0.030 |
Why?
|
Artificial Intelligence | 1 | 2007 | 2557 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2022 | 1868 | 0.030 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 624 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 983 | 0.020 |
Why?
|
Risk Factors | 4 | 2020 | 74333 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2015 | 662 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 4981 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3568 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 755 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2012 | 516 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12968 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 2012 | 286 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2020 | 64981 | 0.020 |
Why?
|
Curriculum | 1 | 2023 | 3718 | 0.020 |
Why?
|
Medicine | 1 | 2018 | 943 | 0.020 |
Why?
|
Radiology Information Systems | 1 | 2014 | 528 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2943 | 0.020 |
Why?
|
Hemostatics | 1 | 2012 | 243 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 867 | 0.020 |
Why?
|
Educational Measurement | 1 | 2016 | 1248 | 0.020 |
Why?
|
Atrophy | 1 | 2014 | 1626 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2012 | 1377 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2754 | 0.020 |
Why?
|
Gold | 1 | 2012 | 484 | 0.020 |
Why?
|
Kinetics | 1 | 2016 | 6377 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2018 | 2554 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2014 | 1403 | 0.020 |
Why?
|
Dogs | 1 | 2012 | 3841 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2023 | 4446 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2019 | 1939 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40139 | 0.020 |
Why?
|
Radiology Department, Hospital | 1 | 2010 | 405 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4902 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2852 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8803 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2884 | 0.020 |
Why?
|
Boston | 1 | 2016 | 9278 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 87809 | 0.010 |
Why?
|
Young Adult | 3 | 2014 | 58748 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15686 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4783 | 0.010 |
Why?
|
Laparoscopy | 1 | 2012 | 2147 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11152 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24102 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9288 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13505 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18413 | 0.010 |
Why?
|
Animals | 2 | 2022 | 167960 | 0.010 |
Why?
|
United States | 1 | 2023 | 72448 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81209 | 0.010 |
Why?
|